Healthcare & Life Sciences
Synthekine
United Stateswww.synthekine.com/
Synthekine is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 2 tracked investors.
series-c-plus
series-c-plus
Stage
2
Investors
About Synthekine
Based in the United States, Synthekine is a startup. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Synthekine designs and develops engineered cytokine therapeutics, including cytokine partial agonists and surrogate cytokine agonists, to treat cancers and autoimmune, inflammatory, and metabolic diseases. Their pipeline includes programs such as STK-012 and the SYNERGY-101 Phase 2 study in non-small cell lung cancer.
Explore Synthekine's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.